ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Louisiana » Nephrology

Top Nephrology Prescribers in Louisiana

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
HOSSEIN TABARI M.D.

Nephrology

28,114

$1.69M

690
484 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

32%
patients receiving schedule three controlled substances

Avg: 5%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 29%

$60
Average prescription price

Avg: $105

JOSHUA LOWENTRITT M.D.

Nephrology

22,869

$1.6M

831
704 are 65+

5%
patients receiving schedule two controlled substances

Avg: 1%

10%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 29%

$70
Average prescription price

Avg: $105

GREGORY MAIDOH M.D.

Nephrology

10,687

$743K

529
367 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

12%
patients receiving schedule three controlled substances

Avg: 5%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 29%

$70
Average prescription price

Avg: $105

SYED RAB MD

Nephrology

9,645

$796K

581
437 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

9%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 29%

$83
Average prescription price

Avg: $105

FRANCISCO CRUZ M.D.

Nephrology

7,581

$1.07M

713
586 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

4%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

34%
prescriptions for brand name drugs

Avg: 29%

$142
Average prescription price

Avg: $105

DAVID POWERS M.D.

Nephrology

7,484

$675K

405
266 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

13%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 29%

$90
Average prescription price

Avg: $105

MARK WILSON M.D.

Nephrology

6,571

$577K

374
220 are 65+

5%
patients receiving schedule two controlled substances

Avg: 1%

20%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 29%

$88
Average prescription price

Avg: $105

FRANCISCO CRUZ M.D.

Nephrology

6,447

$539K

700
576 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

4%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 29%

$84
Average prescription price

Avg: $105

RAPHAEL HIGGINBOTHAM M.D.

Nephrology

6,406

$419K

472
322 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 29%

$65
Average prescription price

Avg: $105

MICHAEL ARCHIE M.D.

Nephrology

6,184

$781K

397
185 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

18%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

37%
prescriptions for brand name drugs

Avg: 29%

$126
Average prescription price

Avg: $105

KENDALL FROM M.D.

Nephrology

6,105

$535K

360
226 are 65+

3%
patients receiving schedule two controlled substances

Avg: 1%

17%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 29%

$88
Average prescription price

Avg: $105

ROBIN BENNETT M.D.

Nephrology

5,411

$466K

325
215 are 65+

5%
patients receiving schedule two controlled substances

Avg: 1%

17%
patients receiving schedule three controlled substances

Avg: 5%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 29%

$86
Average prescription price

Avg: $105

MARWAN KASKAS MD

Nephrology

5,267

$503K

423
257 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

3%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 29%

$96
Average prescription price

Avg: $105

DWAYNE BERGEAUX M.D.

Nephrology

5,074

$503K

336
227 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

6%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 29%

$99
Average prescription price

Avg: $105

MAHESH BASIREDDY MD

Nephrology

5,048

$359K

429
271 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 29%

$71
Average prescription price

Avg: $105

TONY LEUNG MD

Nephrology

4,889

$634K

250
147 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

20%
patients receiving schedule three controlled substances

Avg: 5%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

33%
prescriptions for brand name drugs

Avg: 29%

$130
Average prescription price

Avg: $105

AKSHEY GUPTA M.D.

Nephrology

4,887

$485K

347
216 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

4%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 29%

$99
Average prescription price

Avg: $105

ABDEL ABU SHAMAT MD

Nephrology

4,880

$495K

305
215 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

13%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 29%

$101
Average prescription price

Avg: $105

JOCELYNE SAIKALI M.D.

Nephrology

4,596

$362K

266
174 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

14%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 29%

$79
Average prescription price

Avg: $105

FRED HUSSERL MD

Nephrology

4,565

$434K

261
179 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 29%

$95
Average prescription price

Avg: $105

AMIN KAMYAR M.D.

Nephrology

4,456

$415K

342
224 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 29%

$93
Average prescription price

Avg: $105

APRIL FOX M.D.

Nephrology

4,447

$430K

334
271 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

4%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

35%
prescriptions for brand name drugs

Avg: 29%

$97
Average prescription price

Avg: $105

CHAKKUNGAL DEVIDOSS M.D.

Nephrology

4,326

$538K

432
321 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

33%
prescriptions for brand name drugs

Avg: 29%

$124
Average prescription price

Avg: $105

CHERYL BROWN MD

Nephrology

4,315

$462K

334
283 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

4%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 29%

$107
Average prescription price

Avg: $105

DANIEL MARSH MD

Nephrology

4,225

$473K

338
146 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 5%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 29%

$112
Average prescription price

Avg: $105

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank